Related Articles
Dysregulation of KRAS signaling in pancreatic cancer is not associated with KRAS mutations and outcome
Prevalence of KRAS, BRAF, PI3K and EGFR mutations among Asian patients with metastatic colorectal cancer
EGFR, PIK3CA, KRAS and BRAF mutations in meningiomas
EGFR, ALK, RET, KRAS and BRAF alterations in never-smokers with non-small cell lung cancer
Epidermal growth factor receptor and KRAS mutations in lung adenocarcinoma: A retrospective study of the Lebanese population